Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

HHS awards $55 million to expand virtual healthcare access

The awards will enhance telehealth, digital patient tools and health information technology to support underserved communities.

Thumbnail

Prior authorization adversely impacts patient care, workforce productivity

An AMA survey shows that prior authorization can have harsh consequences on evidence-based care that interfere with a healthy, productive workforce.

Thumbnail

CVS seeks to relieve overworked pharmacists with new policy

Pharmacists have also been affected by the pandemic, with higher than previously reported rates of burnout affecting the profession.

pain pills opioids

CDC updates clinical practice guideline for prescribing opioids

The new guideline suggests prescribing opioid-naïve patients with acute, subacute, or chronic pain the "lowest dosage to achieve expected effects."

Thumbnail

HHS warns hospitals to safeguard against LockBit 2.0 ransomware

While the cybercrime organization claims to not attack healthcare organizations it remains a threat to the entire U.S. healthcare and public health sector, according to a recent alert.

Thumbnail

More states considering legislation to help low-income patients pay high medical debt

The United States Census Bureau reports that 19% of U.S. households could not afford to pay for medical care right away.

Thumbnail

Kaiser Permanente's 'secret' Medicaid deal with California raises eyebrows

The five-year agreement would make Kaiser Permanente the only insurer with a statewide Medi-Cal contract in California.

Thumbnail

Oracle’s $28.3B deal to buy Cerner facing antitrust scrutiny, additional lawsuits

A filing submitted to the Securities and Exchange Commission listed seven civil actions brought forth by Cerner stockholders that suggest disclosure documents contain "insufficient or incorrect" information.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup